Research is essential in developing a better understanding of how the heart and cardiovascular system function, how they become susceptible to disease and how to best combat that disease. By forming collaborative partnerships with industry representatives and academic centers, GHS is at the forefront of scientific advances.
At GHS, research efforts are bringing medical breakthroughs in cardiovascular medicine and device technology to the Upstate.
Researchers at GHS have teamed up with pharmaceutical and medical device companies on several fronts in the treatment of coronary vascular disease, valvular disease, heart failure and cardiac arrhythmias. As a result, GHS patients may be offered the opportunity to participate in the latest national and global clinical trials designed to develop and test new therapies.
Through participation in clinical trials, patients may receive access to the latest therapies before they are widely available to the general public. Our research teams monitor patients carefully throughout a clinical trial and give utmost priority to patient safety.
GHS is one of nine institutions participating in Health Sciences South Carolina (HSSC), a statewide biomedical research collaborative committed to transforming South Carolina’s public health through research.
By combining resources with centers such as Clemson University, the Medical University of South Carolina and the University of South Carolina, GHS can conduct research trials more efficiently and produce results more quickly. HSSC institutions share intellectual talent and physical resources to expand the reach of medical research and offer their resources to a wider array of patients.
In addition to partnering with industry scientists for large-scale clinical trials, GHS physicians are designing local research initiatives to advance patient care and streamline the delivery of health services. Databases are being designed to collect data and track outcomes of patients of the atrial fibrillation, congestive heart failure and valve clinics. Patients who allow their information to be entered into a confidential research database may receive coordinated treatment, including updates about disease trends, risk factors and new treatments.
Since 2009, GHS has hosted a quarterly Cardiovascular Continuing Medical Education Lecture Series for physicians in the Upstate. Nationally renowned experts are invited to GHS to present the latest information on new treatment modalities and quality initiatives in cardiovascular care. The lectures provide physicians with an opportunity to share knowledge and experiences, gain new insights and improve upon the treatments offered to patients.